Stanley Lifestyles Fund Raise of ₹183.9 Cr
Stanley Lifestyles Limited reported zero deviation in the utilisation of ₹183.94 Crore IPO proceeds. Funds were deployed across new stores, anchor stores, renovations, and equipment.
- Value
- ₹183.9 Cr
ALFA Filings
Every announcement, straight from the exchange
Every fund raise announcement on NSE and BSE that our alert engine sent, newest first.
Time
2,009 announcements
Stanley Lifestyles Limited reported zero deviation in the utilisation of ₹183.94 Crore IPO proceeds. Funds were deployed across new stores, anchor stores, renovations, and equipment.
SRM Contractors Ltd confirmed full utilization of its ₹130.20 Crore IPO proceeds. The monitoring agency report was reviewed and approved by the company's Audit Committee.
Nephrocare Health Services Limited submitted its quarterly Monitoring Agency Report for IPO proceeds utilization. Crisil Ratings confirmed ₹353.41 Crore was deployed toward expansion and debt repayment.
Yatharth Hospital submitted its quarterly monitoring report for ₹569.71 Crore in IPO proceeds. While no object deviations occurred, ongoing implementation delays were noted by the agency.
Vraj Iron and Steel Limited reported full utilization of its ₹171 Crore IPO proceeds. No deviations were observed in funds deployed for expansion projects.
Suraj Estate Developers reported utilization of ₹343.39 Crore raised through a preferential issue. The Monitoring Agency confirmed no deviations from the declared objects for this quarter.
JSW Energy reported utilization of ₹1,125 Crore raised through preferential issues for debt repayment. India Ratings confirmed no deviations from stated objectives.
Kaynes Technology submitted quarterly Monitoring Agency Reports for two QIP issues totaling ₹2774 Crore. Proceeds are being utilized for capacity expansion and general corporate purposes.
Akums Drugs and Pharmaceuticals Limited released its monitoring agency report for the March 2026 quarter. It confirms utilization of ₹680.00 Crore IPO proceeds with no deviations.
Standard Engineering Technology Limited released its Q4 FY2026 Monitoring Agency Report. ICRA confirmed ₹232.24 Crore in IPO proceeds are being utilized without any deviations.
SPML Infra Limited reported utilization of ₹210.43 Crore from funds raised via preferential allotment. ICRA's monitoring report confirms zero deviations from stated objects.
Veranda Learning Solutions filed a Monitoring Agency Report confirming utilization of ₹41.25 Crore from its preferential issue. No deviations were observed in fund deployment.
Oval Projects Engineering Limited filed its IPO proceeds monitoring report for March 2026. The company utilized ₹38.96 Crore of ₹46.74 Crore proceeds, with no reported deviations.
Balaji Telefilms Limited reported the utilization status of its ₹130.68 Crore preferential issue proceeds. CRISIL confirmed funds were deployed in line with stated objects.
Aditya Birla Fashion and Retail submitted its Monitoring Agency Report for March 2026. The company confirmed no deviation in utilizing proceeds from its rights and preferential issues.
Sanstar Limited confirmed full utilization of its ₹397.10 Crore public issue proceeds. Acuité Ratings and Research observed no deviations from the stated objects.
Optiemus Infracom Limited submitted its Monitoring Agency Report for the March 2026 quarter. ICRA Limited confirmed the utilization of ₹216.86 Crore from its preferential issue proceeds.
Glen Industries Limited submitted its Regulation 32 Monitoring Agency Report for IPO proceeds totaling ₹62.94 Crore. The report confirms no deviations in fund utilization during the period.
Black Box Limited reported the utilization of ₹386.36 Crore raised via preferential warrant issuance. CARE Ratings verified deployment towards working capital and subsidiaries.
Nilkamal Limited confirmed full utilization of ₹49 Crore raised via Non-Convertible Debentures. There were no deviations from stated objects for the quarter ended March 2026.
LCC Infotech reported full utilization of ₹42.55 Crore raised via preferential issues. The Monitoring Agency confirmed funds were deployed as per stated object documents.
Orchid Pharma Limited submitted its Monitoring Agency Report for the Rs. 400 Crore QIP. The funds are being utilized as per revised shareholder-approved objects.
Nexome Capital Markets approved its quarterly Monitoring Agency Report for Rights Issue proceeds. The board confirmed compliance and management explanations regarding fund utilization.
True Colors Limited reported successful utilization of ₹100.70 Crore IPO proceeds for the quarter. The monitoring agency confirmed no deviations from stated objects during this period.
Beta Drugs Limited reported utilization of ₹117.01 Crore raised through preferential issues. The Monitoring Agency confirms funds were deployed for subsidiary upgradation and R&D.
Purple Wave Infocom released its Monitoring Agency Report confirming utilization of ₹31.45 Crore IPO proceeds. The report notes a deviation in property purchase location.
Kinetic Engineering Ltd filed its Q4 2026 monitoring report for Rs.166.84 Crore warrant proceeds. Funds were utilized for debt reduction, working capital, and subsidiary investments.
Star Imaging and Path Lab Limited reported utilization of its ₹55.66 Crore IPO proceeds. The monitoring agency confirmed no deviations from the stated objects.
Shah Metacorp received stock exchange approvals for a ₹49.80 Crore rights issue. The capital raise strengthens the company's financial position for future growth.
Aditya Infotech Limited submitted its quarterly monitoring agency report for IPO proceeds. The company utilized ₹476.36 Crore with no observed deviations from stated objects.